{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:16:05Z","timestamp":1784888165525,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T00:00:00Z","timestamp":1392854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s40266-014-0156-6","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T10:20:14Z","timestamp":1392805214000},"page":"233-238","source":"Crossref","is-referenced-by-count":68,"title":["Managing Moderate-to-Severe Psoriasis in the Elderly"],"prefix":"10.1007","volume":"31","author":[{"given":"Nicola","family":"Balato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cataldo","family":"Patruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Patr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,20]]},"reference":[{"key":"156_CR1","first-page":"40","volume":"59","author":"F Ayala","year":"2007","unstructured":"Ayala F. Clinical presentation of psoriasis. Reumatismo. 2007;59:40\u20135.","journal-title":"Reumatismo"},{"key":"156_CR2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0190-9622(85)70188-0","volume":"13","author":"T Henseler","year":"1985","unstructured":"Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13:450\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"156_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","volume":"303","author":"U Mrowietz","year":"2011","unstructured":"Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Daud\u00e9n E, Gisondi P, Iversen L, Kem\u00e9ny L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res. 2011;303:1\u201310.","journal-title":"Arch Dermatol Res"},{"key":"156_CR4","first-page":"367475","volume":"2012","author":"JW Wong","year":"2012","unstructured":"Wong JW, Koo JY. The safety of systemic treatments that can be used for geriatric psoriasis patients: a review. Dermatol Res Pract. 2012;2012:367475.","journal-title":"Dermatol Res Pract"},{"key":"156_CR5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2165\/00002512-200219110-00003","volume":"19","author":"G Yosipovitch","year":"2002","unstructured":"Yosipovitch G, Tang MB. Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options. Drugs Aging. 2002;19:847\u201363.","journal-title":"Drugs Aging"},{"key":"156_CR6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.318.7183.593","volume":"318","author":"PG Shekelle","year":"1999","unstructured":"Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ. 1999;318:593\u20136.","journal-title":"BMJ"},{"key":"156_CR7","first-page":"37","volume":"15","author":"R Parslew","year":"2005","unstructured":"Parslew R, Traulsen J. Efficacy and local safety of a calcipotriol\/betamethasone dipropionate ointment in elderly patients with psoriasis vulgaris. Eur J Dermatol. 2005;15:37\u20139.","journal-title":"Eur J Dermatol"},{"key":"156_CR8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000066440","volume":"205","author":"R Kaufmann","year":"2002","unstructured":"Kaufmann R, Bibby AJ, Bissonnette R, Cambazard F, Chu AC, Decroix J, Douglas WS, Lowson D, Mascaro JM, Murphy GM, Stymne B. A new calcipotriol\/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris. Dermatology. 2002;205:389\u201393.","journal-title":"Dermatology"},{"key":"156_CR9","first-page":"140","volume":"90","author":"A Tirado-S\u00e1nchez","year":"2012","unstructured":"Tirado-S\u00e1nchez A, Ponce-Olivera RM. Preliminary study of the efficacy and tolerability of combination therapy with calcipotriene ointment 0.005% and tacrolimus ointment 0.1% in the treatment of stable plaque psoriasis. Cutis. 2012;90:140\u20134.","journal-title":"Cutis"},{"key":"156_CR10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaad.2010.05.014","volume":"65","author":"IS Grozdev","year":"2011","unstructured":"Grozdev IS, Van Voorhees AS, Gottlieb AB, Hsu S, Lebwohl MG, Bebo BF Jr, Korman NJ. Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2011;65:537\u201345.","journal-title":"J Am Acad Dermatol"},{"key":"156_CR11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-0781.2007.00301.x","volume":"23","author":"A Osmancevic","year":"2007","unstructured":"Osmancevic A, Landin-Wilhelmsen K, Lark\u00f6 O, Mellstr\u00f6m D, Wennberg AM, Hulth\u00e9n L, Krogstad AL. UVB therapy increases 25(OH) vitamin D syntheses in postmenopausal women with psoriasis. Photodermatol Photoimmunol Photomed. 2007;23:172\u20138.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"156_CR12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/bmj.298.6676.801","volume":"298","author":"GM Fairris","year":"1989","unstructured":"Fairris GM, Dewhurst AG, White JE, Campbell MJ. Methotrexate dosage in patients aged over 50 with psoriasis. BMJ. 1989;298:801\u20132.","journal-title":"BMJ"},{"key":"156_CR13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2230.1992.tb02161.x","volume":"17","author":"P Collins","year":"1992","unstructured":"Collins P, Rogers S. The efficacy of methotrexate in psoriasis\u2014a review of 40 cases. Clin Exp Dermatol. 1992;17:257\u201360.","journal-title":"Clin Exp Dermatol"},{"key":"156_CR14","unstructured":"Adalimumab [package insert], North Chicago; 2002. http:\/\/www.accessdata.fda.gov\/drugsatfdadocs\/label\/2002\/adalabb123102LB.htm ."},{"key":"156_CR15","unstructured":"Infliximab [package insert], Janssen, Toronto; 2010. http:\/\/www.remicade.com\/remicade\/assets\/HCPPPI.pdf ."},{"key":"156_CR16","unstructured":"Ustekinumab [package insert], Janssen Biotech, Horsham; 2011. http:\/\/www.drugs.com\/pro\/stelara.html ."},{"key":"156_CR17","unstructured":"Etanercept [package insert], Amgen, Thousand Oaks; 1998\u20132011. http:\/\/pi.amgen.com\/unitedstates\/enbrel\/derm\/enbrelpi.pdf ."},{"key":"156_CR18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaad.2006.02.010","volume":"55","author":"G Militello","year":"2006","unstructured":"Militello G, Xia A, Stevens SR, Van Voorhees AS. Etanercept for the treatment of psoriasis in the elderly. J Am Acad Dermatol. 2006;55:517\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"156_CR19","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaad.2009.09.040","volume":"63","author":"A Menter","year":"2010","unstructured":"Menter A, Gordon KB, Leonardi CL, Gu Y, Goldblum OM. Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis. J Am Acad Dermatol. 2010;63:448\u201356.","journal-title":"J Am Acad Dermatol"},{"key":"156_CR20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","volume":"50","author":"JB Galloway","year":"2011","unstructured":"Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Fu B, Ustianowski AP, Watson KD, Lunt M, Symmons DP. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6\u00a0months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology. 2011;50:124\u201331.","journal-title":"Rheumatology"},{"key":"156_CR21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/ard.2005.035287","volume":"65","author":"R Fleischmann","year":"2006","unstructured":"Fleischmann R, Baumgartner SW, Weisman MH, Liu T, White B, Peloso P. Long term safety of etanercept in elderly subjects with rheumatic diseases. Ann Rheum Dis. 2006;65:379\u201384.","journal-title":"Ann Rheum Dis"},{"key":"156_CR22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00002512-200623030-00003","volume":"23","author":"A Flamminger","year":"2006","unstructured":"Flamminger A, Maibach H. Drug dosage in the elderly: dermatological drugs. Drugs Aging. 2006;23:203\u201315.","journal-title":"Drugs Aging"},{"issue":"6","key":"156_CR23","first-page":"999","volume":"71","author":"M Nadai","year":"2013","unstructured":"Nadai M, Katoh M. Changes in pharmacokinetics in elderly patients. Nihon Rinsho. 2013;71(6):999\u20131003.","journal-title":"Nihon Rinsho"},{"key":"156_CR24","first-page":"279","volume":"15","author":"P Gisondi","year":"2005","unstructured":"Gisondi P, Girolomoni G, Sampogna F, Tabolli S, Abeni D. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalized for psoriasis. Eur J Dermatol. 2005;15:279\u201383.","journal-title":"Eur J Dermatol"},{"key":"156_CR25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2005.03.046","volume":"53","author":"JM Gelfand","year":"2005","unstructured":"Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53:573.","journal-title":"J Am Acad Dermatol"},{"key":"156_CR26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00128071-200506060-00005","volume":"6","author":"AB Kimball","year":"2005","unstructured":"Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6:383\u201392.","journal-title":"Am J Clin Dermatol"},{"key":"156_CR27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","volume":"32","author":"T Henseler","year":"1995","unstructured":"Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32:982\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"156_CR28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","volume":"55","author":"AL Neimann","year":"2006","unstructured":"Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829\u201335.","journal-title":"J Am Acad Dermatol"},{"key":"156_CR29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11926-006-0065-8","volume":"8","author":"L Mallbris","year":"2006","unstructured":"Mallbris L, Ritchlin CT, Stahle M. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep. 2006;8:355\u201363.","journal-title":"Curr Rheumatol Rep"},{"key":"156_CR30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/B:EJEP.0000020447.59150.f9","volume":"19","author":"L Mallbris","year":"2004","unstructured":"Mallbris L, Akre O, Granath F, Yin L, Lindel\u00f6f B, Ekbom A, St\u00e5hle-B\u00e4ckdahl M. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol. 2004;19:225\u201330.","journal-title":"Eur J Epidemiol"},{"key":"156_CR31","first-page":"1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. J Am Acad Dermatol. 2006;296:1735\u201341.","journal-title":"J Am Acad Dermatol"},{"key":"156_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2006.07.011","volume":"190","author":"M Wakkee","year":"2007","unstructured":"Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis. 2007;190:1\u20139.","journal-title":"Atherosclerosis"},{"key":"156_CR33","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0264-410X(99)00489-2","volume":"18","author":"G Wick","year":"2000","unstructured":"Wick G, Jansen-D\u00fcrr P, Berger P, Blasko I, Grubeck-Loebenstein B. Diseases of aging. Vaccine. 2000;18:1567\u201383.","journal-title":"Vaccine"},{"key":"156_CR34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1513\/pats.200508-081JS","volume":"2","author":"KC Meyer","year":"2005","unstructured":"Meyer KC. Aging. Proc Am Thorac Soc. 2005;2:433\u20139.","journal-title":"Proc Am Thorac Soc"},{"key":"156_CR35","first-page":"928","volume":"9","author":"C Leonardi","year":"2010","unstructured":"Leonardi C, Strober B, Gottlieb AB, Elewski BE, Ortonne JP, van de Kerkhof P, Chiou CF, Dunn M, Jahreis A. Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study. J Drugs Dermatol. 2010;9:928\u201337.","journal-title":"J Drugs Dermatol"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-014-0156-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-014-0156-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-014-0156-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:41:53Z","timestamp":1559504513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-014-0156-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,20]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["156"],"URL":"https:\/\/doi.org\/10.1007\/s40266-014-0156-6","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,20]]}}}